These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18952655)

  • 21. Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis.
    Kojima F; Naraba H; Miyamoto S; Beppu M; Aoki H; Kawai S
    Arthritis Res Ther; 2004; 6(4):R355-65. PubMed ID: 15225371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription factor, SP1, in epiretinal membranes of patients with proliferative diabetic retinopathy.
    Yoshida-Hata N; Mitamura Y; Oshitari T; Namekata K; Harada C; Harada T; Yamamoto S
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e26-8. PubMed ID: 20047772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
    Abu El-Asrar AM; Van den Steen PE; Al-Amro SA; Missotten L; Opdenakker G; Geboes K
    Int Ophthalmol; 2007 Feb; 27(1):11-22. PubMed ID: 17375263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J; Lu Q; Tao Y; Jiang YR
    Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes.
    Xu J; Zhong H; Cui L; Lan Q; Chen L; He W; Wu Y; Jiang L; Huang H; Zhao X; Li L; Zeng S; Li M; Xu F
    Oncotarget; 2017 May; 8(22):35532-35541. PubMed ID: 28402943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
    Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
    Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
    Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
    Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Despite transcriptional and functional coordination, cyclooxygenase-2 and microsomal prostaglandin E synthase-1 largely reside in distinct lipid microdomains in WISH epithelial cells.
    Ackerman WE; Robinson JM; Kniss DA
    J Histochem Cytochem; 2005 Nov; 53(11):1391-401. PubMed ID: 15983118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of inducible microsomal prostaglandin E synthase in local lesions of endometriosis patients.
    Chishima F; Hayakawa S; Yamamoto T; Sugitani M; Karasaki-Suzuki M; Sugita K; Nemoto N
    Am J Reprod Immunol; 2007 Mar; 57(3):218-26. PubMed ID: 17295901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
    von Rahden BH; Brücher BL; Langner C; Siewert JR; Stein HJ; Sarbia M
    Br J Surg; 2006 Nov; 93(11):1424-32. PubMed ID: 17022010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer.
    Cathcart MC; Gately K; Cummins R; Drakeford C; Kay EW; O'Byrne KJ; Pidgeon GP
    Biochim Biophys Acta; 2014 May; 1842(5):747-55. PubMed ID: 24480048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression and regulation of cylooxygenases, prostaglandin E synthases and prostacyclin synthase in rat uterus during the peri-implantation period.
    Cong J; Diao HL; Zhao YC; Ni H; Yan YQ; Yang ZM
    Reproduction; 2006 Jan; 131(1):139-51. PubMed ID: 16388017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2.
    de Oliveira AC; Candelario-Jalil E; Bhatia HS; Lieb K; Hüll M; Fiebich BL
    Glia; 2008 Jun; 56(8):844-55. PubMed ID: 18383341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines.
    van Rees BP; Sivula A; Thorén S; Yokozaki H; Jakobsson PJ; Offerhaus GJ; Ristimäki A
    Int J Cancer; 2003 Nov; 107(4):551-6. PubMed ID: 14520691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.
    El-Asrar AM; Missotten L; Geboes K
    Mol Vis; 2011 Feb; 17():508-18. PubMed ID: 21365018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
    Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
    Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apelin in epiretinal fibrovascular membranes of patients with retinopathy of prematurity and the changes after intravitreal bevacizumab.
    Zhang Y; Jiang YR; Lu Q; Yin H; Tao Y
    Retina; 2013 Mar; 33(3):613-20. PubMed ID: 23296045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy.
    Katome T; Namekata K; Mitamura Y; Semba K; Egawa M; Naito T; Harada C; Harada T
    J Diabetes Complications; 2015 Mar; 29(2):275-81. PubMed ID: 25468312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.